Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG.
Rosengart TK, et al. Among authors: hachamovitch r.
Circulation. 1999 Aug 3;100(5):468-74. doi: 10.1161/01.cir.100.5.468.
Circulation. 1999.
PMID: 10430759
Clinical Trial.